Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes

被引：0
|
作者：
A. Hemeryck
C. De Vriendt
F. M. Belpaire
机构：
[1] Heymans Institute of Pharmacology,
[2] University of Gent Medical School,undefined
[3] 9000 Gent,undefined
[4] Belgium e-mail: frans.belpaire@rug.ac.be Tel.: +32-9-2403355; Fax: +32-9-2404988,undefined
来源：
European Journal of Clinical Pharmacology | 1999年 / 54卷
关键词：
Key words CYP2C9; SSRI; (S)-warfarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To investigate the in vitro potential of selective serotonin reuptake inhibitors (SSRIs) to inhibit two CYP2C9-catalysed reactions, tolbutamide 4-methylhydroxylation and (S)-warfarin 7-hydroxylation.
引用
收藏
页码：947 / 951
页数：4
相关论文
共 50 条
  • [1] Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes
    Hemeryck, A
    De Vriendt, C
    Belpaire, FM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 54 (12) : 947 - 951
  • [2] Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: Studies of phenytoin para-hydroxylation
    Schmider, J
    Greenblatt, DJ
    vonMoltke, LL
    Karsov, D
    Shader, RI
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 511 - 511
  • [3] Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: Studies of phenytoin p-hydroxylation
    Schmider, J
    Greenblatt, DJ
    vonMoltke, LL
    Karsov, D
    Shader, RI
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (05) : 495 - 498
  • [4] Inhibition of tamoxifen metabolism by selective serotonin reuptake inhibitors in human liver microsomes
    Kondo, Hiroshi
    Ishiwata, Kazuya
    Suzuki, Hisashi
    Shibasaki, Shigeki
    Kurosawa, Toru
    DRUG METABOLISM REVIEWS, 2006, 38 : 99 - 99
  • [5] Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone:: In vitro studies using human liver microsomes
    Hemeryck, A
    De Vriendt, C
    Belpaire, FM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (04) : 428 - 434
  • [6] Effect of albumin and cytosol on enzyme kinetics of tolbutamide Hydroxylation and on inhibition of CYP2C9 by gemfibrozil in human liver microsomes
    Wang, JS
    Wen, X
    Backman, JT
    Neuvonen, PJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01): : 43 - 49
  • [7] The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors
    Belpaire, FM
    Wijnant, P
    Temmerman, A
    Rasmussen, BB
    Brosen, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) : 261 - 264
  • [8] The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors
    F. M. Belpaire
    P. Wijnant
    A. Temmermann
    B. B. Rasmussen
    K. Brøsen
    European Journal of Clinical Pharmacology, 1998, 54 : 261 - 264
  • [9] SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND THEOPHYLLINE METABOLISM IN HUMAN LIVER-MICROSOMES - POTENT INHIBITION BY FLUVOXAMINE
    RASMUSSEN, BB
    MAENPAA, J
    PELKONEN, O
    LOFT, S
    POULSEN, HE
    LYKKESFELDT, J
    BROSEN, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (02) : 151 - 159
  • [10] The inhibition of CYP1A2, CYP2C9, and CYP2D6 by pterostilbene in human liver microsomes
    Albassam, A. A.
    Ahad, A.
    Alsultan, A.
    Yusufoglu, H. S.
    Foudah, A., I
    Al-Jenoobi, F., I
    PHARMAZIE, 2021, 76 (04): : 155 - 158
12345